Stockreport
Erythropoietin Stimulating Agents Market Size to Reach USD 16.81 Billion by 2033, Driven by Rising chronic kidney disease and Chemotherapy-Induced Anemia Cases – SNS Insider [Yahoo! Financ...
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Austin, Texas, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Erythropoietin Stimulating Agents Market Size & Growth Analysis: According to SNS Insider, the global Erythropoietin Stimulating Agents Market is estimated to be valued at USD 10.79 billion in 2025 and is projected to reach USD 16.81 billion by 2033, growing at a CAGR of 5.72% during the forecast period of 2026–2033. Erythropoietin Stimulating Agents Market growth is primarily driven by the rising prevalence of chronic kidney disease (CKD) and chemotherapy-induced anemia, which continue to generate sustained demand for anemia management therapies. Increasing prescription volumes, expanding clinical adoption, and improving access through biosimilars further support market growth. Get a Sample Report of Erythropoietin Stimulating Agents Market: https://www.snsinsider.com/sample-request/8534 U.S. Erythropoietin Stimulating Agents Market Insights The U.S. Erythropoietin Stimulating Agents (ESA) Market is estimated to be valued at U
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Amgen Inc. (AMGN): A Bull Case Theory [Yahoo! Finance][Yahoo! Finance]
- Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $335.00. They now have an "outperform" rating on the stock.[MarketBeat]
- Amgen (NASDAQ:AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $400.00 to $403.00. They now have a "buy" rating on the stock.[MarketBeat]
- Amgen CEO: There are a bunch of ways to win for patients when it comes to weight loss [CNBC][CNBC]
- Amgen CEO Bob Bradway goes one-on-one with Jim Cramer [CNBC][CNBC]
- More
AMGN
SEC Filings
SEC Filings
- 11/21/25 - Form 4
- 11/20/25 - Form 144
- 11/13/25 - Form 4
- AMGN's page on the SEC website
- More